Elevated liver enzymes resulting from an interaction between Raltegravir and Panax ginseng: A case report and brief review

Drug Metabolism and Drug Interactions

Volumn 27, Issue 3, 2012, Pages 171-175

  Mateo Carrasco, Héctor ^a   Gálvez Contreras, María C ^a   Fern Ández Ginés, Francisco D ^a   Nguyen, Timothy V ^b,c  

^a Torrec Á Rdenas Hospital   (Spain)

^b LONG ISLAND UNIVERSITY   (United States)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Antiretroviral therapy; Drug herb interactions; Drug induced liver injury; P anax ginseng

Indexed keywords

ACETYLSALICYLIC ACID; COTRIMOXAZOLE; CYTOCHROME P450 3A4; ENERGISIL VIGOR GINSENG; ESOMEPRAZOLE; GINSENG EXTRACT; LOPINAVIR PLUS RITONAVIR; RALTEGRAVIR; UNCLASSIFIED DRUG;

ADULT; CASE REPORT; CLINICAL FEATURE; COMORBIDITY; DRUG INDUCED DISEASE; GASTROINTESTINAL SYMPTOM; HERB DRUG INTERACTION; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERTRANSAMINASEMIA; JAUNDICE; LABORATORY TEST; LIVER INJURY; LYMPHOCYTE COUNT; MALAISE; MALE; MEDICAL HISTORY; MITOCHONDRIAL TOXICITY; PHYSICAL EXAMINATION; PNEUMOCYSTIS PNEUMONIA; PROPHYLAXIS; REVIEW; SEXUAL DYSFUNCTION; THROMBOSIS; TREATMENT OUTCOME; VIRUS LOAD;

COMPLEMENTARY THERAPIES; CYTOCHROME P-450 CYP3A; DRUG-INDUCED LIVER INJURY; HERB-DRUG INTERACTIONS; HIV INFECTIONS; HIV INTEGRASE INHIBITORS; HUMANS; LIVER; MALE; MIDDLE AGED; PANAX; PYRROLIDINONES;

EID: 84869421468     PISSN: 07925077     EISSN: None     Source Type: Journal    
DOI: 10.1515/dmdi-2012-0019     Document Type: Review

References (31)

1. Chan TW, But PP, Cheng, SW, Kwok IM, Lau FW, Xu HX. Differentiation and authentication of Panax ginseng, Panax quinquefolius and ginseng products by using HPCL/MS. Anal Chem 2000;72:2329.
2. Jiang X, Williams KM, Liauw WS, Ammit AJ, Roufogalis BD, Duke CC, et al. Effect of St John's wort and ginseng on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects. Br J Clin Pharmacol 2004;57:592-9. (Pubitemid 38582179)
3. Sotaniemi EA, Haapakoski E, Rautio A. Ginseng therapy in non-insulin-dependent diabetic patients: effects on psychophysical performance, glucose homeostasis, serum lipids, serum aminoterminalpropeptide concentration, and body weight. Diab Care 1995;18:1373-5.
4. Lee HJ, Kim SR, Kim JC, Kang CM, Lee YS, Jo SK, et al. In vivo radioprotective effect of Panax ginseng and identification of active ginsenosides. Phytother Res 2006;20:392-5.
5. Shin HR, Kim JY, Yun TK, Morgan G, Vainio H. The cancerpreventive potential of Panax ginseng: a review of human and experimental evidence. Cancer Causes Control 2000;11:565-76. (Pubitemid 30342846)
6. Scaglione F, Weiser K, Alessandria M. Effects of the standardized ginseng extract G115 (Reg.) in patients with chronic bronchitis: a nonblinded, randomized, comparative pilot study. Clin Drug Invest 2001;21:41-5. (Pubitemid 32128496)
7. Sung H, Jung YS, Cho YK. Beneficial effects of a combination of Korean red ginseng and highly active antiretroviral therapy in human immunodeficiency virus type 1-infected patients. Clin Vaccine Immunol 2009;16:1127-31.
8. Cho M, Ye X, Dobs A, Cofrancesco J. Prevalence of complementary and alternative medicine use among HIV patients for perceived lipodystrophy. J Alt Compl Med 2006;12: 475-82. (Pubitemid 44061505)
9. Owen-Smith A, Diclemente R, Wingood G. Complementary and alternative medicine use decreases adherence to HAART in HIV-positive women. AIDS Care 2007;19: 589-93. (Pubitemid 46763748)
10. Vázquez M, Hurtado MF, Blanco JG. The influence of alternative medicine in highly active antiretroviral treatment. Farm Hosp 2009;33:31-6.
11. Patel J, Buddha B, Dey S, Pal D, Mitra AK. In vitro interaction of the HIV protease inhibitor ritonavir with herbal constituents: changes in P-gp and CYP3A4 activity. Am J Ther 2004;11:262-77.
12. The US National Library of Medicine. Pubmed®. Available at: http://www.ncbi.nlm.nih.gov/pubmed. Accessed: February 10, 2012.
13. Therapeutic Research Faculty. Natural Medicines Comprehensive Database®. Available at: http://naturaldatabase. therapeuticresearch.com. Accessed: February 10, 2012.
14. The University of Liverpool. HIV Drug Interactions®. Available at: http://www.hiv-druginteractions.org/Interactions.aspx. Accessed: February 10, 2012.
15. Centro Andaluz de Farmacovigilancia (Andalusian Center for Pharmaco-Surveillance). Available at: https://ws027.juntadeandalucia. es/cs/farmacovigilancia/notifica.asp Accessed: November 18, 2011.
16. Pikuleva IA. Cytochrome P450s and cholesterol homeostasis. Pharmacol Ther 2006;112:761-73. (Pubitemid 44573496)
17. Hao M, Zhao Y, Chen P, Huang H, Liu H, Jiang H, et al. Structureactivity relationship and substrate-dependent phenomena in effects of ginsenosides on activities of drug-metabolizing P450 enzymes. PLoS One 2008;3:e2697.
18. Saxena A, Tripathi KP, Roy S, Khan F, Sharma A. Pharmacovigilance: effects of herbal components on human drug interactions involving cytochrome P450. Bioinformation 2008;3:198-204.
19. Henderson GL, Harkey MR, Gershwin ME, Hackman RM, Stern JS, Stresser DM. Effects of ginseng components on c-DNA-expressed cytochrome P450 enzyme catalytic activity. Life Sci 1999;65:PL209-14.
20. He N, Edeki T. The inhibitory effects of herbal components on CYP2C9 and CYP3A4 catalytic activities in human liver microsomes. Am J Ther 2004;11:206-12.
21. Gurley BJ, Gardner SF, Hubbard MA, Hubbard DK, Gentry DB, Cuy Y, et al. Clinical assessment of effects of botanical supplementation on cytochrome P450 phenotypes in the elderly: St John's wort, garlic oil, Panax ginseng and Ginkgo biloba. Drugs Aging 2005;22:525-39. (Pubitemid 41003065)
22. Donovan JL, DeVane CL, Chavin KD, Chavin KD, Taylor RM, Markowitz JS. Siberian ginseng (Eleutheroccus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 2003;31:519-22. (Pubitemid 36444158)
23. Gurley BJ, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Cuy Y, et al. Cytochrome P450 phenotypic ratios for predicting herb-drug interactions in humans. Clin Pharmacol Ther 2002;72:276-87.
24. Smith M, Lin KM, Zheng YP. An open trial of nifedipine-herb interactions: nifedipine with St. John's wort, ginseng or ginko biloba. Clin Pharmacol Ther 2001;69:P86.
25. Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother 2007;41:674-80. (Pubitemid 46625492)
26. Nin Chau T, Cheung WI, Ngan T, Lin J, Lee KWS, Poon WT, et al. Causality assessment of herb-induced liver injury using multidisciplinary approach and Roussel Uclaf Causality Assessment Method (RUCAM). Clin Tox 2011;49:34-9.
27. García-Cortés M, Stephens C, Lucena MI, Fernández-Castaner A, Andrade RJ. Causality assessment methods in drug induced liver injury: strengths and weaknesses. J Hepatol 2011;55: 683-91.
28. Bilgi N, Bell K, Ananthakrishnan AN, Ataliah E. Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity. Ann Pharmacother 2010;44:926-8.
29. Chuang WC, Wu HK, Sheu SJ, Chiou SH, Chang HC, Chen YP. A comparative study on commercial samples of ginseng radix. Planta Med 1995;61:459-65.
30. The review of natural products by facts and comparisons. St. Louis, MO: Wolters Kluwer Co, 1999.
31. UCB Pharma S.A. Septrin Forte (Trimethoprim/Sulfamethoxazole 800/160 mg) drug data sheet. Available at: http://www. vademecum.es/medicamento-septrin forte-3626. Accessed: October 20, 2011.